IGHG3 and myeloid sarcoma: Among the IgG-positive RR-MS patients (n = 13), 6 (46%) exhibited high levels of IgG1, and 7 (54%) showed substantial levels IgG4, while IgG2 and IgG3 levels were not detected in the sera (Figure 1B).